Association of Gut Microbiota With Intestinal Ischemia/Reperfusion Injury
Overview
Infectious Diseases
Microbiology
Affiliations
Intestinal ischemia/reperfusion (II/R) is a common acute and critical condition in clinical practice with a high mortality rate. However, there is still a lack of effective prevention and treatment measures for II/R injury. The role of the gut microbiota in II/R has attracted widespread attention. Recent evidence has demonstrated that the gut microbiota plays a pivotal role in the occurrence, development, and prognosis of II/R. Therefore, maintaining the homeostasis of gut microbiota and its metabolites may be a potential strategy for the treatment of II/R. This review focuses on the importance of crosstalk between the gastrointestinal ecosystem and II/R to highlight II/R-induced gut microbiota signatures and potential applications of microbial-based therapies in II/R. This will also provide potentially effective biomarkers for the prediction, diagnosis and treatment of II/R.
Wang Q, Yu Z, Nie L, Wang F, Mu G, Lu B Front Cell Infect Microbiol. 2024; 14:1491639.
PMID: 39687547 PMC: 11647003. DOI: 10.3389/fcimb.2024.1491639.
Prevalence and predictive value of sarcopenia in hospitalized patients with ischemic colitis.
Ahn B, Sagong M, Kim J, Park M, Bae J, Wook Lee J Sci Rep. 2024; 14(1):14352.
PMID: 38906968 PMC: 11192930. DOI: 10.1038/s41598-024-65243-6.
Zhang L, Gong X, Tan J, Zhang R, Li M, Liu C Biol Direct. 2024; 19(1):23.
PMID: 38500127 PMC: 10946149. DOI: 10.1186/s13062-024-00462-5.
Kashyap Y, Wang Z Pain. 2023; 165(2):423-439.
PMID: 37733476 PMC: 10843763. DOI: 10.1097/j.pain.0000000000003034.
Chen Y, Han B, Guan X, Du G, Sheng B, Tang X J Adv Res. 2023; 61:223-237.
PMID: 37717911 PMC: 11258666. DOI: 10.1016/j.jare.2023.09.008.